Biomarker, method for searching disease-related gene, and renal cancer marker

A biomarker and disease technology, applied in the field of kidney cancer markers, which can solve problems such as comparative research on microvesicles

Inactive Publication Date: 2019-06-18
JAPANESE FOUND FOR CANCER RES +1
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, the research results reported so far mainly use cultured cells, and there is no data comparing microvesicles obtained from diseased sites and normal sites with the same histological background.
Therefore, whether it functions as an effective biomarker in the diagnosis of disease or the development of new drugs is still questionable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarker, method for searching disease-related gene, and renal cancer marker
  • Biomarker, method for searching disease-related gene, and renal cancer marker
  • Biomarker, method for searching disease-related gene, and renal cancer marker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] [Example 1] The separation method of Te-EVs

[0065] figure 1 It is a schematic diagram showing a method for isolating tissue-exudative extracellular vesicles (tissue-exudative EVs, hereinafter sometimes referred to as Te-EVs.) from diseased tissues and analyzing biomarkers. Diseased tissues and normal tissues are excised from surgically removed tissues, and immediately immersed in an immersion solution. In the case of renal cell carcinoma, serum-free DMEM was used as the immersion solution, but the immersion solution can be appropriately selected according to the tissue from which Te-EVs are extracted. Since extracellular vesicles are contained in serum, a serum-free medium is preferably used as the immersion solution, but a serum-containing medium may also be used if extracellular vesicles are removed in advance.

[0066] The tissue slices taken from the disease site and normal site were allowed to stand in the soaking solution at 4°C for about 1 hour to secrete ext...

Embodiment 2

[0068] [Example 2] Purification of kidney tissue-derived extracellular vesicles

[0069] Te-EVs were collected and analyzed from both cancerous tissues and normal tissues (non-cancerous parts) obtained from 20 renal cell carcinoma patients. Histological diagnosis of renal cell carcinoma was performed by hematoxylin-eosin staining. The disease stages of patients classified based on the AJCC TNM 6th edition were T1a to T3c.

[0070] The degree of refinement of the resulting extracellular vesicles was analyzed by Western blotting, immunoelectron microscopy, nanoparticle tracking ( figure 2 ) and mass spectrometry ( image 3) for analysis. Western blotting was performed by a conventional method using 100 ng each of the obtained Te-EVs proteins. As primary antibodies, anti-CD63 monoclonal antibody (8A12), anti-CD81 monoclonal antibody (12C4), and anti-CD9 monoclonal antibody (12A12) (all manufactured by Cosmo Bio) were used as exosome markers. The antibody was detected by ECL...

Embodiment 3

[0078] To investigate the properties of the resulting Te-EVs, the expression levels of tetraspanin molecules were compared. Fifteen tetraspanin molecules were detected, and Te-EVs derived from any tissue were shown to be highly refined substances. Furthermore, it became clear that the expression of most molecules of the tetraspanin superfamily was decreased in Te-EVs derived from cancer tissues compared with Te-EVs derived from normal tissues. [Example 3] Analysis of Te-EVs in cancer tissues and normal tissues in renal cell carcinoma

[0079] Using cancer tissues obtained from 20 patients and Te-EVs derived from normal tissues around the cancer site as a control, LC / MS analysis was performed in the same manner as above ( Figure 4 ). A total of 3871 proteins were identified, of which 160 were specifically expressed in Te-EVs derived from normal tissues, 253 were specifically expressed in Te-EVs derived from cancerous tissues, and 3458 were co-expressed in both ( Figure 4 A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided is a method in which an affected tissue and a normal tissue obtained from the vicinity of the affected tissue are left at rest in a culture medium, and a disease-specific biomarker is searched for in an exudate therefrom. By means of the method, a biomarker specific to renal cell cancer has been discovered.

Description

technical field [0001] The invention relates to a method for isolating and refining extracellular vesicles, identifying biomarkers and disease-associated genes, and an inspection method. In addition, it relates to a kidney cancer marker obtained by using this search method. Background technique [0002] Biomarkers refer to substances or image data in living organisms that are related to normal or pathological processes of the body, or pharmacological responses to treatments, and become objective indicators of the state of the body. Biomarkers include various markers such as biochemical tests, blood tests, so-called clinical test values ​​such as tumor markers, and image diagnostic data such as CT or MRI. In particular, biomarkers that represent the presence or classification of diseases as indicators of diseases are indispensable in current medical treatments such as discovery, diagnosis, and prediction of prognosis of diseases. In addition, in the development of new drugs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68C12Q1/68G01N33/15G01N33/50G01N33/574G01N33/92
CPCC12Q1/6886C12Q2600/158G01N33/57438G01N33/57488G01N2333/4721G01N33/574G01N33/92G01N33/50G01N33/68
Inventor 植田幸嗣大西直美野野村祝夫植村元秀藤田和利辻川和丈神宫司健太郎
Owner JAPANESE FOUND FOR CANCER RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap